Be sure to check out these recently published articles: Congrats to Kelsey Krus (DiAntonio/Milbrandt labs) on her paper demonstrating that loss of STMN2 in mice induces slowly progressive motor deficits, a cardinal feature of ALS. Exciting work from the DiAntonio...
March 4, 2022: Congratulations to Caitlin Dingwall and the Milbrandt/DiAntonio labs on their new preprint, “Macrophage depletion blocks congenital SARMI-dependent neuropathy”.
The Milbrandt Lab collaborated on a paper with the Wu Lab from Harvard Medical School and the DiAntonio Lab at Washington University School of Medicine, “Multiple domain interfaces mediate SARM1 autoinhibition.” Chen Shen, a postdoc in the Wu Lab, is lead...
The Milbrandt and DiAntonio Labs have a new paper in eLife, “SARM1 depletion rescues NMNAT1 dependent photoreceptor cell death and retinal degeneration.” Yo Sasaki, PhD, Associate Professor in the Department of Genetics at Washington University School of...
The DiAntonio and Milbrandt Labs published a paper in the Journal of Cell Biology, “SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.” Kwang Woo Ko, a postdoc in the DiAntonio Lab, is lead author on the...
The Buchser, DiAntonio, and Milbrandt Labs have published a paper in Scientific Data, “Domain-centric database to uncover structure of minimally characterized viral genomes.” Jack Bramley, a lead scientist in the Buchser Lab, is lead author on the paper. ...
The Milbrandt and DiAntonio Labs have a new preprint, “SARM1 depletion rescues NMNAT1 dependent photoreceptor cell death and retinal degeneration.” Yo Sasaki, PhD, Associate Professor in the Department of Genetics at Washington University School of...
Kow Essuman, a graduate student in the Milbrandt Lab, and Alex Russo, a graduate student in the DiAntonio Lab, are finalists for the O’Leary Prize. As finalists, Kow and Alex will give short presentations of their research at the O’Leary Prize Competition on...
The Milbrandt and DiAntonio labs had a paper published recently on gene therapy that blocks peripheral damage in mice. The paper, “Gene therapy targeting SARM1 blocks pathological axon degeneration in mice,” appears in a recent issue of the Journal of...
